Pharma Pulse: UPS's Cold-Chain Buildout and AbbVie's $10.9B Immunology Bet

Jun 25, 12:00 PM
Headliner
Share
Subscribe
In this week's Pharma Pulse, UPS commits $48 million to cold-chain infrastructure, AbbVie moves to acquire Apogee Therapeutics in a $10.9 billion deal, and more.
Share
Subscribe
Next
Pharma Pulse: What the USMCA Joint Review Means for Pharma
Top episodes
Overcoming Supply Chain Challenges
by Pharma Pulse
Incorporating AI into Commercialization Plans
by Pharma Pulse
The Capabilities of a 3PL Provider
by Pharma Pulse